产品特点
Issued: September 2013
AN: 00538/2012
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Marbocare flavour 5mg tablets for dogs and cats (UK and IE)
Marbocare F 5mg tablets for dogs and cats (FR)
Odimar 5mg tablets for dogs and cats (BE, LU, NL)
Marbofloxacin WDT 5mg flavoured tablets for cats and dogs (AT, DE)
Marbofloxacino Emdoka 5mg tablets for cats and dogs (ES)
Marbofloxacina Emdoka 5mg tablets for cats and dogs (PT)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
EACH TABLET CONTAINS:
ACTIVE SUBSTANCE: Marbofloxacin 5.0 mg
EXCIPIENTS:
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet
Beige brown spotted round tablets with a score line on one side.
4.
CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs and Cats
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Marbofloxacin is indicated in the treatment of the following infections caused by
susceptible strains of organisms (see section 5.1);
Dogs
Skin and soft tissue infections (skinfold pyoderma, impetigo, folliculitis,
furunculosis, cellulitis)
Urinary tract infections (UTI) associated or not with prostatitis or epididymitis
Respiratory tract infections
Issued: September 2013
AN: 00538/2012
Page 2 of 6
Cats
Skin and soft tissue infections (wounds, abscesses, phlegmons)
Upper respiratory tract infections
4.3 CONTRAINDICATIONS
Do not use in dogs aged less than 12 months, or less than 18 months for exceptionally
large breeds of dogs, such as Great Danes, Briard, Bernese, Bouvier and Mastiffs, with
a longe
阅读完整的文件